{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-161950","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2025-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.778539+00:00","generated_at":"2026-05-18T05:09:45.766708+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Avantor names Emmanuel Ligner as President and CEO effective August 18, 2025","bullets":["Ligner succeeds Michael Stubblefield, who steps down as previously announced.","Ligner brings 30+ years in life sciences; formerly CEO of Cytiva and Cerba HealthCare.","Initial annual base salary £775,000; target bonus 150% of base; one-time equity award $5M.","Eligible for annual equity grant target value $9M starting 2026 under equity plan.","Severance upon involuntary termination: lump-sum $75,000 for repatriation plus standard plan terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-161950","json":"https://secwatch.observer/filing/0001193125-25-161950.json","markdown":"https://secwatch.observer/filing/0001193125-25-161950.md","text":"https://secwatch.observer/filing/0001193125-25-161950.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000119312525161950/0001193125-25-161950-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000119312525161950/d69795d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:09:45.766708+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}